Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

NVO TEVA AGN FRX Furniture Raw Materials Action Alerts Education 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Collecting data for FRX

Forest quote and profile

 
 Companies |  Insiders  | Dashboard  
     
41.84
  
STOCK
0.27  Macroaxis: 0.65 Up   0.65%  
Year To Date
31.2843.85
Last 1 Month(s)
37.5141.84
Trading Day 
41.3443.85
June 19 2013 

Diversification Suggestion

Use Forest to enhance returns of your portfolios. The stock experiences moderate upward volatility
Analyze Forest Laboratories Trend or Check current 30 days Forest correlation with market (S&P 500)
1 Month Beta 0.96  
Highest Price:  
Lowest Price:  
41.57  
37.51  
June 18 2013 
May 22 2013 
Forest returns are very sensitive to returns on the market. As market goes up or down, Forest is expected to follow.
Forest Laboratories Inc llmost one BetaForest Laboratories Beta Legend
FRX United States NYSE
Forest Laboratories Inc
Healthcare
Drug Manufacturers - Other
Benchmark S&P 500
http://www.frx.com
Contact Number: 212. 421. 7850
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation8.54 B
Shares Outstanding266.28 M
Number of Shares Shorted4.27 M
Revenue3.1 B
 thisGreen FRX FRX agains markets  0.65 % Macroaxis: 0.65 Moved Up  
 
 United States Russel   1.35 % Macroaxis: change 1.35 Moved Down  
 
 United States SP 500   1.39 % Macroaxis: change 1.39 Moved Down  
 
 United States NYSE   1.53 % Macroaxis: change 1.53 Moved Down  
 
Compare to Competition Alpha & Beta   Get Advice

Forest Leadership

Howard Solomon Chairman, CEO and Pres
Marco Taglietti Senior Vice President - Research and Development and Presidentident - Forest Research Institute, Ph.D
Kevin Walsh Senior Vice President and Director - Operations
Jerome Lynch Senior Vice President - Sales

Forest Price and Market Media

The median price of Forest for the period between Mon, May 20, 2013 and Wed, Jun 19, 2013 is 40.09 with a coefficient of variation of 2.67. The daily time series for the period is distributed with a sample standard deviation of 1.07, arithmetic mean of 39.93, and mean deviation of 0.76. The Stock received some media coverage during the period.
Forest         SP 500
Price Growth (%)
 
Change Benchmark  Embed  Export  Timeline
1
Ironwood Pharmaceuticals Inc. Forest Laboratories Inc. Three...05/29/2013Macroaxis: News
2
Forest Laboratories Upgraded to Buy at Argus06/06/2013Macroaxis: News
3
Discovery Communications Takes Over 314 Spot From Forest Lab...06/12/2013Macroaxis: Forbes News

Forest Summary

Forest Laboratories Inc [FRX] is traded on New York Stock Exchange in USA. It is located in New York, NY and employs 5,700 people. The company currently falls under 'Mid-Cap' category with total capitalization of 9.99 B. Forest Laboratories Inc runs under Healthcare sector within Drug Manufacturers - Other industry. This company has 266.28 M outstanding shares of which 4.27 M shares are currently shorted by investors with about 3.1 days to cover shorted positions.
Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug solutions primarily in the United States and Europe. more
Past Market
Over 30
Days
14
Out Of
100
 
Chance of
Less
Than
42 %
 
Follow Forest with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Forest to your reader
 

Forest Research Report

Forest vs. Novo

Correlation analysis and fundamentals comparison between Forest Laboratories and Novo Nordisk A-S

Forest Executives

Francis Perier CFO, Executive VP of Fin. and Admin. and Member of Disclosure, Legal Compliance and Risk Management Committee

Forest Directors

Kenneth Goodman Presiding Independent Director
Lawrence Olanoff Director
Pierre Legault Director
Christopher Coughlin Director
Lester Salans Director

Forest Fundamentals

Return On Asset vs Total Asset
EBITDA vs Price to Earnings To Growth
Return On Asset vs Working Capital
Retained Earnings vs Price to Earnings To Growth

Forest vs Competition

Forest vs. Novo Nordisk A-S
Forest vs. Teva Pharmaceutical Industries Limited
Forest vs. Allergan Inc
Forest vs. Dr Reddys Laboratories Ltd
Forest vs. Pharmacyclics Inc
Forest vs. Warner Chilcott plc
Forest vs. Endo Health Solutions Inc
Forest vs. Cubist Pharmaceuticals Inc
Forest vs. United Therapeutics Corporation

Forest June 19 2013 Opportunity Range

Downside Deviation1.29
Information Ratio0.281
Maximum Drawdown8.31
Value At Risk(1.24)
Potential Upside3.01

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium